{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:50:34Z","timestamp":1791179434884,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Respir Med"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1007\/bf03256636","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T04:05:17Z","timestamp":1345694717000},"page":"21-29","source":"Crossref","is-referenced-by-count":105,"title":["Serotonin Agonists and Antagonists in Obstructive Sleep Apnea"],"prefix":"10.1007","volume":"2","author":[{"given":"Sigrid C.","family":"Veasey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,20]]},"reference":[{"key":"BF03256636_CR1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","volume":"328","author":"T Young","year":"1993","unstructured":"Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230\u20135","journal-title":"N Engl J Med"},{"key":"BF03256636_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1164\/ajrccm.162.1.9905035","volume":"162","author":"Y Peker","year":"2000","unstructured":"Peker Y, Hedner J, Kraiczi H, et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81\u20136","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256636_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","volume":"163","author":"E Shahar","year":"2001","unstructured":"Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19\u201325","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256636_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0034-5687(99)00113-9","volume":"119","author":"BG Phillips","year":"2000","unstructured":"Phillips BG, Somers VK. Neural and humoral mechanisms mediating cardiovascular responses to obstructive sleep apnea. Respir Physiol 2000; 119: 181\u20137","journal-title":"Respir Physiol"},{"key":"BF03256636_CR5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/pcad.1999.0410341","volume":"41","author":"R Day","year":"1999","unstructured":"Day R, Gerhardstein R, Lumley A, et al. The behavioral morbidity of obstructive sleep apnea. Prog Cardiovasc Dis 1999; 41: 341\u201354","journal-title":"Prog Cardiovasc Dis"},{"key":"BF03256636_CR6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/ajrccm.162.2.9908091","volume":"162","author":"R Shultz","year":"2000","unstructured":"Shultz R, Mahmoudi S, Hattar K, et al. Enhanced release of Superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566\u201370","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256636_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0098-2997(00)00005-4","volume":"21","author":"JF Keaney Jr","year":"2000","unstructured":"Keaney Jr JF. Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction. Mol Aspects Med 2000; 21: 99\u20131666","journal-title":"Mol Aspects Med"},{"key":"BF03256636_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1164\/ajrccm\/147.4.887","volume":"147","author":"NB Kribbs","year":"1993","unstructured":"Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147: 887\u201395","journal-title":"Am Rev Respir Dis"},{"key":"BF03256636_CR9","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/sleep\/19.suppl_9.S90","volume":"19","author":"JL Pepin","year":"1996","unstructured":"Pepin JL, Veale D, Mayer P, et al. Critical analysis of the results of surgery in the treatment of snoring, upper airway resistance syndrome (UARS), and obstructive sleep apnea (OSA). Sleep 1996; 19: S90\u2013S100","journal-title":"Sleep"},{"key":"BF03256636_CR10","first-page":"S172","volume":"23","author":"AA Lowe","year":"2000","unstructured":"Lowe AA, Sjoholm TT, Ryan CF, et al. Treatment, airway and compliance effects of a titratable oral appliance. Sleep 2000; 23: S172\u20138","journal-title":"Sleep"},{"key":"BF03256636_CR11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1378\/chest.112.3.629","volume":"112","author":"A Oksenberg","year":"1997","unstructured":"Oksenberg A, Silverberg DS, Arons E, et al. Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. Chest 1997; 112: 629\u201339","journal-title":"Chest"},{"key":"BF03256636_CR12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00063198-200011000-00006","volume":"6","author":"R Goldberg","year":"2000","unstructured":"Goldberg R. Treatment of obstructive sleep apnea, other than with continuous positive airway pressure. Curr Opin Pulm Med 2000; 6: 496\u2013500","journal-title":"Curr Opin Pulm Med"},{"key":"BF03256636_CR13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/arrd.1983.127.4.487","volume":"127","author":"PM Suratt","year":"1983","unstructured":"Suratt PM, Dee P, Atkinson RL, et al. Fluoroscopic and computed tomographic features of the pharyngeal airway in obstructive sleep apnea. Am Rev Respir Dis 1983; 127: 487\u201392","journal-title":"Am Rev Respir Dis"},{"key":"BF03256636_CR14","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI115751","volume":"89","author":"WS Mezzanotte","year":"1992","unstructured":"Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89: 1571\u20139","journal-title":"J Clin Invest"},{"key":"BF03256636_CR15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/jappl.1978.44.6.931","volume":"44","author":"JE Remmers","year":"1978","unstructured":"Remmers JE, deGroot WJ, Sauerland EK, et al. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978; 44: 931\u20138","journal-title":"J Appl Physiol"},{"key":"BF03256636_CR16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0034-5687(99)00106-1","volume":"119","author":"RL Horner","year":"2000","unstructured":"Horner RL. Impact of brainstem mechanisms on pharyngeal motor control. Respir Physiol 2000; 119: 113\u201321","journal-title":"Respir Physiol"},{"key":"BF03256636_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0034-5687(00)00164-X","volume":"122","author":"AJ Berger","year":"2000","unstructured":"Berger AJ. Determinants of respiratory motoneuron output. Respir Physiol 2000; 122: 259\u201369","journal-title":"Respir Physiol"},{"key":"BF03256636_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0014-4886(87)90179-8","volume":"96","author":"PJ Soja","year":"1987","unstructured":"Soja PJ, Finch DM, Chase MH. Effect of inhibitory amino acid antagonists on masseteric reflex suppression during active sleep. Exp Neurol 1987; 96:178\u201393","journal-title":"Exp Neurol"},{"key":"BF03256636_CR19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1523\/JNEUROSCI.09-03-00743.1989","volume":"9","author":"MH Chase","year":"1989","unstructured":"Chase MH, Soja PJ, Morales FR. Evidence that glycine mediates the postsynaptic potentials that inhibit lumbar motoneurons during the atonia of active sleep. J Neurosci 1989; 9: 743\u201351","journal-title":"J Neurosci"},{"key":"BF03256636_CR20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1152\/jn.1997.78.1.129","volume":"78","author":"MC Xi","year":"1997","unstructured":"Xi MC, Liu RH, Yamuy J, et al. Electrophysiological properties of lumber motoneurons in the alpha-chloralose-anesthetized cat during carbachol-induced motor inhibition. J Neurophysiol 1997; 78: 129\u201336","journal-title":"J Neurophysiol"},{"key":"BF03256636_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(80)90390-8","volume":"65","author":"RB McCall","year":"1980","unstructured":"McCall RB, Aghajanian GK. Pharmacological characterization of serotonin receptors in the facial motor nucleus: a microiontophoretic study. Eur J Pharm 1980; 65: 175\u201383","journal-title":"Eur J Pharm"},{"key":"BF03256636_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0006-8993(90)90586-Z","volume":"515","author":"I Kurasawa","year":"1990","unstructured":"Kurasawa I, Toda K, Nakamura Y. Non-reciprocal facilitation of trigeminal motoneurons innervating jaw-closing and jaw-opening muscles induced by iontophoretic application of serotonin in the guinea pig. Brain Res 1990; 515: 126\u201334","journal-title":"Brain Res"},{"key":"BF03256636_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-8993(91)91318-U","volume":"550","author":"LE Ribeiro-do-Valle","year":"1991","unstructured":"Ribeiro-do-Valle LE, Metzler CW, Jacobs BL. Facilitation of masseter EMG and masseteric (jaw-closure) reflex by serotonin in behaving cats. Brain Res 1991; 550: 197\u2013204","journal-title":"Brain Res"},{"key":"BF03256636_CR24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0304-3940(92)90257-8","volume":"143","author":"AJ Berger","year":"1992","unstructured":"Berger AJ, Bayliss DA, Viana F. Modulation of neonatal rat hypoglossal motoneuron excitability by serotonin. Neurosci Lett 1992; 143: 164\u20138","journal-title":"Neurosci Lett"},{"key":"BF03256636_CR25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0304-3940(92)90563-M","volume":"139","author":"L Kubin","year":"1992","unstructured":"Kubin L, Tojima H, Davies RO, et al. Serotonergic excitatory drive to the hypoglossal motoneurons in the decerebrate cat. Neurosci Lett 1992; 139: 243\u20138","journal-title":"Neurosci Lett"},{"key":"BF03256636_CR26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-8993(96)00335-6","volume":"726","author":"MA Douse","year":"1996","unstructured":"Douse MA, White DP. Serotonergic effects on hypoglossal neural activity and reflex responses. Brain Res 1996; 726: 213\u201322","journal-title":"Brain Res"},{"key":"BF03256636_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0034-5687(97)00079-0","volume":"110","author":"DA Bayliss","year":"1997","unstructured":"Bayliss DA, Viana F, Talley EM, et al. Neuromodulation of hypoglossal motoneurons: cellular and developmental mechanisms. Respir Physiol 1997; 110: 139\u201350","journal-title":"Respir Physiol"},{"key":"BF03256636_CR28","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1523\/JNEUROSCI.15-07-05346.1995","volume":"15","author":"SC Veasey","year":"1995","unstructured":"Veasey SC, Fornal CA, Metzler CW, et al. Response of serotonergic caudal raphe neurons in relation to specific motor activities in freely moving cats. J Neurosci 1995; 15: 5346\u201359","journal-title":"J Neurosci"},{"key":"BF03256636_CR29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0166-2236(93)90090-9","volume":"16","author":"BL Jacobs","year":"1993","unstructured":"Jacobs BL, Fornal CA. 5-HT and motor control: a hypothesis. Trends Neurosci 1993; 16: 346\u201352","journal-title":"Trends Neurosci"},{"key":"BF03256636_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-8993(82)90743-0","volume":"251","author":"J Heym","year":"1982","unstructured":"Heym J, Steinfels GF, Jacobs BL. Activity of serotonin-containing neurons in the nucleus raphe pallidus of freely-moving cats. Brain Res 1982; 251: 259\u201376","journal-title":"Brain Res"},{"key":"BF03256636_CR31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0006-8993(94)91663-2","volume":"645","author":"L Kubin","year":"1994","unstructured":"Kubin L, Reigner C, Tojima H, et al. Changes in serotonin level in the hypoglossal nucleus region during carbachol-induced atonia. Brain Res 1994; 645: 291\u2013302","journal-title":"Brain Res"},{"key":"BF03256636_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/sleep\/19.3.187","volume":"19","author":"L Kubin","year":"1996","unstructured":"Kubin L, Tojima H, Reignier C, et al. Interaction of serotonergic excitatory drive to hypoglossal motoneurons with carbachol-induced, REM sleep-like atonia. Sleep 1996; 19: 187\u201395","journal-title":"Sleep"},{"key":"BF03256636_CR33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1469-7793.2001.0467f.x","volume":"532","author":"A Jelev","year":"2001","unstructured":"Jelev A, Sood S, Liu H, et al. Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats. J Physiol 2001; 532: 467\u201381","journal-title":"J Physiol"},{"key":"BF03256636_CR34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1164\/ajrccm.153.2.8564132","volume":"153","author":"SC Veasey","year":"1996","unstructured":"Veasey SC, Panckeri KA, Hoffman EA, et al. The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med 1996; 153: 776\u20138","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256636_CR35","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1164\/ajrccm.160.5.9812007","volume":"160","author":"SC Veasey","year":"1999","unstructured":"Veasey SC, Fenik P, Panckeri K, et al. The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 1999; 160: 1659\u201367","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256636_CR36","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1152\/jappl.1987.63.4.1344","volume":"64","author":"JC Hendricks","year":"1987","unstructured":"Hendricks JC, Kline LR, Kovalski RJ, et al. The English bulldog: a natural model of sleep-disordered breathing. J Appl Physiol 1987; 64: 1344\u201350","journal-title":"J Appl Physiol"},{"key":"BF03256636_CR37","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1471-4159.1991.tb02052.x","volume":"56","author":"GS Sarna","year":"1991","unstructured":"Sarna GS, Hutson PH, O\u2019Connell MT, et al. Effect of tryptophan on extracellular concentrations of tryptophan and 5-hydroxyindoleacetic acid in the striatum and cerebellum. J Neurochem 1991; 56: 1564\u20138","journal-title":"J Neurochem"},{"key":"BF03256636_CR38","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.2042-7158.1982.tb04701.x","volume":"34","author":"MH Fong","year":"1982","unstructured":"Fong MH, Garatini S, Caccia S. 1-m-chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole. J Pharm Pharmacol 1982; 34: 674\u20135","journal-title":"J Pharm Pharmacol"},{"key":"BF03256636_CR39","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharm 1999; 38: 1083\u2013152","journal-title":"Neuropharm"},{"key":"BF03256636_CR40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0034-5687(97)00080-7","volume":"110","author":"S Okabe","year":"1997","unstructured":"Okabe S, Mackiewicz M, Kubin L. Serotonin receptor mRNA expression in the hypoglossal motor nucleus. Respir Physiol 1997; 110: 151\u201360","journal-title":"Respir Physiol"},{"issue":"1","key":"BF03256636_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0306-4522(02)00137-9","volume":"113","author":"G Zhan","year":"2002","unstructured":"Zhan G, Shaheen F, Mackiewicz M, et al. Single cell laser dissection with molecular beacon polymerase chain reaction identifies 2A as the predominant serotonin receptor subtype in hypoglossal motoneurons. Neuroscience 2002; 113(1): 145\u201354","journal-title":"Neuroscience"},{"key":"BF03256636_CR42","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1093\/sleep\/19.suppl_10.150","volume":"19","author":"S Okabe","year":"1996","unstructured":"Okabe S, Kubin L. Role of 5HT1 receptors in the control of hypoglossal motoneurons in vivo. Sleep 1996; 19: S150\u20133","journal-title":"Sleep"},{"key":"BF03256636_CR43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/sleep\/24.8.871","volume":"24","author":"P Fenik","year":"2001","unstructured":"Fenik P, Ogawa H, Veasey SC. Hypoglossal nerve response to drugs injected into the XII nucleus and vena cava in the rat. Sleep 2001; 24: 871\u20138","journal-title":"Sleep"},{"key":"BF03256636_CR44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0006-8993(87)90174-0","volume":"417","author":"JR Holtman Jr","year":"1987","unstructured":"Holtman Jr JR, Dick TE, Berger AJ. Serotonin-mediated excitation of recurrent laryngeal and phrenic motoneurons evoked by stimulation of the raphe obscurus. Brain Res 1987; 417: 12\u201320","journal-title":"Brain Res"},{"key":"BF03256636_CR45","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0028-3908(90)90151-G","volume":"29","author":"DA Jackson","year":"1990","unstructured":"Jackson DA, White SR. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons. Neuropharm 1990; 29: 787\u201397","journal-title":"Neuropharm"},{"key":"BF03256636_CR46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/syn.890050409","volume":"5","author":"K Rasmussen","year":"1990","unstructured":"Rasmussen K, Aghajanian GK. Serotonin excitation of facial motoneurons: receptor subtype characterization. Synapse 1990; 5: 324\u201332","journal-title":"Synapse"},{"key":"BF03256636_CR47","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s004240050089","volume":"431","author":"ZA Al-Zubaidy","year":"1996","unstructured":"Al-Zubaidy ZA, Erickson RL, Greer JJ. Serotonergic and noradrenergic effects on respiratory neural discharge in the medullary slice preparation of neonatal rats. Pflugers Archiv 1996; 431: 942\u20139","journal-title":"Pflugers Archiv"},{"key":"BF03256636_CR48","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1152\/jn.1997.77.6.2910","volume":"77","author":"CF Hsiao","year":"1997","unstructured":"Hsiao CF, Trueblood PR, Levine MS, et al. Multiple effects of serotonin on membrane properties of trigeminal motoneurons in vitro. J Neurophysiol 1997; 77: 2910\u201324","journal-title":"J Neurophysiol"},{"key":"BF03256636_CR49","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1152\/jn.1999.82.2.626","volume":"82","author":"T Inoue","year":"1999","unstructured":"Inoue T, Itoh S, Kobayashi M, et al. Serotonergic modulation of the hyperpolarizing spike afterpotential in rat jaw-closing motoneurons by PKA and PKC. J Neurophysiol 1999; 82: 626\u201337","journal-title":"J Neurophysiol"},{"key":"BF03256636_CR50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1152\/jn.1990.63.2.356","volume":"63","author":"N Katakura","year":"1990","unstructured":"Katakura N, Chandler SH. An iontophoretic analysis of the pharmacologic mechanisms responsible for trigeminal motoneuronal discharge during masticatory-like activity in the guinea pig. J Neurophysiol 1990; 63: 356\u201369","journal-title":"J Neurophysiol"},{"key":"BF03256636_CR51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1113\/jphysiol.1992.sp019347","volume":"456","author":"PM Larkman","year":"1992","unstructured":"Larkman PM, Kelly JS. Ionic mechanisms mediating 5-hydroxytryptamine- and noradrenaline-evoked depolarization of adult rat facial motoneurones. J Physiol 1992; 456: 473\u201390","journal-title":"J Physiol"},{"key":"BF03256636_CR52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0028-3908(97)00021-X","volume":"36","author":"PM Larkman","year":"1997","unstructured":"Larkman PM, Kelly JS. Modulation of IH by 5-HT in neonatal rat motoneurones in vitro: mediation through a phosphorylation independent action of cAMP. Neuropharm 1997; 36: 721\u201333","journal-title":"Neuropharm"},{"key":"BF03256636_CR53","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1113\/jphysiol.1995.sp020907","volume":"487","author":"PM Lalley","year":"1995","unstructured":"Lalley PM, Bischoff AM, Schwarzacher SW, et al. 5-HT2 receptor-controlled modulation of medullary respiratory neurones in the cat. J Physiol 1995; 487: 653\u201361","journal-title":"J Physiol"},{"key":"BF03256636_CR54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(94)90159-7","volume":"259","author":"R Monteau","year":"1994","unstructured":"Monteau R, Di Pasquale E, Hilaire G. Further evidence that various 5-HT receptor subtypes modulate central respiratory activity: in vitro studies with SR 46349B. Eur J Pharm 1994; 259: 71\u20134","journal-title":"Eur J Pharm"},{"key":"BF03256636_CR55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0034-5687(95)00008-2","volume":"101","author":"D Rose","year":"1995","unstructured":"Rose D, Khater-Boidin J, Toussaint P, et al. Central effects of 5-HT on respiratory and hypoglossal activities in the adult cat. Respir Physiol 1995; 101: 59\u201369","journal-title":"Respir Physiol"},{"key":"BF03256636_CR56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(85)91515-X","volume":"327","author":"BJ Sessle","year":"1985","unstructured":"Sessle BJ, Henry JL. Effects of enkephalin and 5-hydroxytryptamine on solitary tract neurons involved in respiration and respiratory reflexes. Brain Res 1985; 327: 221\u201330","journal-title":"Brain Res"},{"key":"BF03256636_CR57","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1476-5381.1991.tb12452.x","volume":"104","author":"SC Sporton","year":"1991","unstructured":"Sporton SC, Shepheard SL, Jordan D, et al. Microinjections of 5-HT1A agonists into the dorsal motor nucleus produce a bradycardia in the atenolol-pretreated anesthetized rat. Br J Pharm 1991; 104: 466\u201370","journal-title":"Br J Pharm"},{"key":"BF03256636_CR58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00584777","volume":"389","author":"PM Sutton","year":"1981","unstructured":"Sutton PM. The interaction between reflex apnoea and bradycardia produced by injecting 5-HT into the nodose ganglion. Pflugers Arch 1981; 389: 181\u20137","journal-title":"Pflugers Arch"},{"key":"BF03256636_CR59","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-3565(25)11383-9","volume":"260","author":"M Yoshioka","year":"1992","unstructured":"Yoshioka M, Goda Y, Togashi H, et al. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. J Pharm Exp Therap 1992; 260: 917\u201324","journal-title":"J Pharm Exp Therap"},{"key":"BF03256636_CR60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/sleep\/21.2.131","volume":"21","author":"M Radulovacki","year":"1998","unstructured":"Radulovacki M, Trbovic SM, Carley DW. Serotonin 5-HT3-receptor antagonist GR 38032F suppresses sleep apnea in rats. Sleep 1998; 21: 131\u20136","journal-title":"Sleep"},{"key":"BF03256636_CR61","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.115.5.1397","volume":"115","author":"DW Carley","year":"1999","unstructured":"Carley DW, Radulovacki M. Role of peripheral serotonin in the regulation of central sleep apnea in rats. Chest 1999; 115: 1397\u2013401","journal-title":"Chest"},{"key":"BF03256636_CR62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/sleep\/24.2.155","volume":"24","author":"SC Veasey","year":"2001","unstructured":"Veasey SC, Chachkes J, Fenik P, et al. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 2001; 24: 155\u201360","journal-title":"Sleep"},{"key":"BF03256636_CR63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/ajrccm.161.2.9810091","volume":"161","author":"H Nakano","year":"2000","unstructured":"Nakano H, Magalang UJ, Lee S-D, et al. Serotonergic modulation of ventilation and upper airway stability in obese Zucker rats. Am J Respir Crit Care Med 2000; 161: 347\u201352","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256636_CR64","first-page":"327","volume":"40","author":"JM Launay","year":"1994","unstructured":"Launay JM, Callebert J, Bondoux D, et al. Serotonin receptors and therapeutics. Cell Mol Biol 1994; 40: 327\u201336","journal-title":"Cell Mol Biol"},{"key":"BF03256636_CR65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0361-9230(94)00221-L","volume":"36","author":"T Kubo","year":"1995","unstructured":"Kubo T, Taguchi K, Ozaki S, et al. 8-OH-DPAT-induced hypotensive action and sympathoexcitatory neurons in the rostral ventrolateral medulla of the rat. Brain Res Bull 1995; 36: 405\u201311","journal-title":"Brain Res Bull"},{"key":"BF03256636_CR66","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1067\/mcp.2000.110502","volume":"68","author":"JN Hoon de","year":"2000","unstructured":"de Hoon JN, Willigers JM, Troost J, et al. Vascular effects of 5-HT1B\/1D-receptor agonists in patients with migraine headaches. Clin Pharm Ther 2000; 68:418\u201326","journal-title":"Clin Pharm Ther"},{"key":"BF03256636_CR67","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.bjp.0702822","volume":"128","author":"ID Knowles","year":"1999","unstructured":"Knowles ID, Ramage AG. Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats. Br J Pharm 1999; 128: 530\u201342","journal-title":"Br J Pharm"},{"key":"BF03256636_CR68","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02805987","volume":"127","author":"J Benjamin","year":"1996","unstructured":"Benjamin J, Greenberg BD, Murphy DL. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects. Psychopharm 1996; 127: 140\u20139","journal-title":"Psychopharm"},{"key":"BF03256636_CR69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00685640","volume":"37","author":"J Carmichael","year":"1995","unstructured":"Carmichael J, Philip PA, Forfar C, et al. An open study to assess the safety, tolerance and pharmacokinetics of an intravenous infusion of granisetron given at 3mg over 30s in patients receiving chemotherapy for malignant disease. Cancer Chemother Pharmacol 1995; 37: 134\u20138","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF03256636_CR70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s002100000333","volume":"363","author":"CM Villalon","year":"2001","unstructured":"Villalon CM, Sanchez-Lopez A, Centurion D, et al. Unravelling the pharmacological profile of the canine external carotid vasodilator \u20185-HT1-like\u2019receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 73\u201380","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF03256636_CR71","first-page":"244","volume":"129","author":"RM Wittig","year":"1984","unstructured":"Wittig RM, Romaker A, Zorick FJ, et al. Night-to-night consistency of apneas during sleep. Am Rev Respir Dis 1984; 129: 244\u20136","journal-title":"Am Rev Respir Dis"},{"key":"BF03256636_CR72","first-page":"625","volume":"19","author":"HS Schmidt","year":"1983","unstructured":"Schmidt HS. L-tryptophan in the treatment of impaired respiration in sleep. Bull Eur Physiopathol Respir 1983; 19: 625\u20139","journal-title":"Bull Eur Physiopathol Respir"},{"key":"BF03256636_CR73","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/00007611-199209000-00005","volume":"85","author":"KE Sack","year":"1992","unstructured":"Sack KE, Criswell LA. Eosinophilic-myalgia syndrome: the aftermath. South Med J 1992; 85: 878\u201382","journal-title":"South Med J"},{"key":"BF03256636_CR74","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.68031326.x","volume":"68","author":"A Gobert","year":"1997","unstructured":"Gobert A, Rivet JM, Cistarelli JM, et al. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. J Neurochem 1997; 68: 1326\u20139","journal-title":"J Neurochem"},{"key":"BF03256636_CR75","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1164\/ajrccm\/141.6.1527","volume":"141","author":"WB Mendelson","year":"1990","unstructured":"Mendelson WB, Martin JV, Rapoport DM. Effects of buspirone on sleep and respiration. Am Rev Respir Dis 1990; 141: 1527\u201330","journal-title":"Am Rev Respir Dis"},{"key":"BF03256636_CR76","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1378\/chest.100.2.416","volume":"100","author":"DA Hanzel","year":"1991","unstructured":"Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991; 100: 416\u201321","journal-title":"Chest"},{"key":"BF03256636_CR77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1472-8206.1996.tb00145.x","volume":"10","author":"AM Gardier","year":"1996","unstructured":"Gardier AM, Malagie I, Trillat AC, et al. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 1996; 10: 16\u201327","journal-title":"Fundam Clin Pharmacol"},{"key":"BF03256636_CR78","first-page":"61","volume":"22","author":"H Kraiczi","year":"1999","unstructured":"Kraiczi H, Hedner J, Dahlof P, et al. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999; 22: 61\u20137","journal-title":"Sleep"},{"key":"BF03256636_CR79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/sleep\/22.8.1087","volume":"22","author":"RB Berry","year":"1999","unstructured":"Berry RB, Yamaura EM, Gill K, et al. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep 1999; 22: 1087\u201392","journal-title":"Sleep"},{"key":"BF03256636_CR80","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410230417","volume":"23","author":"EF Salazar-Grueso","year":"1988","unstructured":"Salazar-Grueso EF, Rosenberg RS, Roos RP. Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone. Ann Neurol 1988; 23: 399\u2013401","journal-title":"Ann Neurol"},{"key":"BF03256636_CR81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0034-5687(96)00079-5","volume":"106","author":"CR Richmonds","year":"1996","unstructured":"Richmonds CR, Hudgel DW. Hypoglossal and phrenic motoneuron responses to serotonergic active agents in rats. Respir Physiol 1996; 106: 153\u201360","journal-title":"Respir Physiol"},{"key":"BF03256636_CR82","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1164\/ajrccm.160.6.9902090","volume":"160","author":"DW Carley","year":"1999","unstructured":"Carley DW, Radulovacki M. Mirtazapine, a mixed-profile serotonin in agonist\/antagonist, suppresses sleep apnea in rats. Am J Respir Crit Care Med 1999; 160: 1824\u20139","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03256636_CR83","doi-asserted-by":"crossref","unstructured":"Veasey SC. Pharmacological trials for sleep-disordered breathing. In: Pack AI, editor. Pathogenesis, diagnosis and treatment of sleep apnea. New York: Marcel Dekker, 607\u201322","DOI":"10.1201\/b14008-22"}],"container-title":["American Journal of Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03256636\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T03:39:07Z","timestamp":1743997147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03256636"}},"subtitle":["Therapeutic Potential"],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["BF03256636"],"URL":"https:\/\/doi.org\/10.1007\/bf03256636","relation":{},"ISSN":["1175-6365"],"issn-type":[{"value":"1175-6365","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}